{"id":867855,"date":"2025-07-09T08:34:26","date_gmt":"2025-07-09T12:34:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/"},"modified":"2025-07-09T08:34:26","modified_gmt":"2025-07-09T12:34:26","slug":"maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/","title":{"rendered":"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025"},"content":{"rendered":"<div class=\"mw_release\">\n<p>ROCKVILLE, Md., July  09, 2025  (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2025 after the U.S. market close on Wednesday, August 6<sup>th<\/sup>, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time.<\/p>\n<p>\n        <strong>Earnings Conference Call Details<\/strong><br \/>\n        <br \/>Investors interested in listening to the conference call are required to <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rbm-x1hHfsxNnWfiTyM65z7O5Q1Q0kYttMHU0VAuN6SLWdVA20s1pRXyHu1AWKePK8L7CuEsQa4hIomOqXpAfqiPJcSMBFx4I85WdNXcDowLhz-MkhwXS0S7xBgPkLfLP4ow5elS01hhRwtiDLXqHOzVXZFp956Qg_q4EabnguUrIzt7yiq7ngnSibqcxMAC_gmpSCq5zVUIHERMYTpSUPTSasS3-F2MVt4CiyCTtSFLDGPHr9jxc_3nUBqjoCFeHEF2vPspEkMr2bRkYpLp3QR8L-vXYbLcTmkV9o7H3vyznab7-C-7Ana3T2bpyNKkjbZbqblNHGEIRJAmq0r1pBjwRBRJndnZKspEWrMopil5wODvzD5C2lanLIsyObKkIZEJ1zw4rZ24mnDQYdA11c_NxK_O2AfAU-foRX3-t2FfbNsabiS48cxcl2DAsc5JeBj-q0ExvcZWTUbUArAQ6g==\" rel=\"nofollow\" target=\"_blank\">register online<\/a>. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SRD8zb7eTf_s0OP_H4JOFCCCO2L0GqaPWUyGEEJZUnRh9L5lo-nx3PAbLOWGBYUHnGfxst6MEFxfnfeZavFlxs3HOoeif6zZ5oevF8PhDhDum1BNkotqQoVv_fuAuPgm\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.maxcyte.com\/<\/a>.<\/p>\n<p>\n        <strong>About MaxCyte<\/strong><\/p>\n<p>At MaxCyte<sup>\u00ae<\/sup>, we are committed to building better cells together. As a leading cell-engineering company, we are driving the discovery, development and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation<sup>\u00ae<\/sup>\u00a0technology and SeQure DX\u2122 gene editing risk assessment services enable precise, efficient and scalable cell engineering. Supported by expert scientific, technical and regulatory guidance, our platform empowers researchers from around the world to engineer diverse cell types and payloads, accelerating the development of safe and effective treatments for human health. For more than 25 years, we&#8217;ve been advancing cell engineering, shaping the future of medicine. Learn more at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QK5_68BuYfeI4Grtkz_ng_GOklSMBGEvSMImuHHhtsGkDr_LeXdoZ4dNWGTuv_7UcBYOpqdh7HnpYmXDHi1HT8x4UGV6-CqsAL6Aa3L7isAHUatFXo0GbLsdWbiU28R8xuDf95GvUg6wGZEtsddq5ewJBV9s6ACyg-nLSZTlccTCdKOsj8j-3kyKJdFjGR9IkPGgjA39DSOdEqE9MpbmeXeZ7jdZNj4BLWyiwkIacf6nzr4jj8n37BUu8rlGfKXADfXIwHIv5wmG-1vIvoorWCddesYz0tVrHqGEg0DQRqqbQXbxoLdmDbdq1oTgs5AplIXbsPwStpMA1Se1JKndUcpPjnSyIN4oXaU7vCigDA0QyjbPbCla-TgTYmz2uzmKzpAvwcfBUtAJ6f-ruBnxGimFMPoQN_vieSo8PofJmUAtnMkQKbJzdNOrlCd9S4ZU2FSK36d8hxjkC9_LOGPIhO3rocIs1kdGpJpS-WCqwwVkr9T0C783RkJerxCigYMC5qawHhE8GVmQtlqjjZr2gb1f4RNhoN3oJ2okogU-mc5Z-XJgZcDJnPd-wxXz_QcL3KE6AEAw41ZpBJ7tvKCiYKvX_zMknNltraPBL4FHUu4Ajgqg4-L4fFPAORDO_Sxx\" rel=\"nofollow\" target=\"_blank\">maxcyte.com<\/a>\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=k-eAImE0i_BfbcnLL01RVZxD5vjP9uaPvbJo0Q9Wu7ZqiYIExVKjELjIS5b3RHVkyBxHNS14fysq2xYULAhX5RU3DgFJ78ovJyGfBHRK2Klv4T6ZqWQCmTVJw4F0EUuoU1SiuCtipXPFMqvLPTujIjmed9rdEW8mhqZ4yiWiGrWoodCR5GZD_ccuZwww58VHlmmnvDdjCbtVoyfpJHv6yjR0-LQjkC6Ax5bsE0D5dwFpMy3QFJe7rCrlKEdyqNSNI8o9GA9awinn9pRng684juYgJMYAs0giurjcM3ZCwWm02_0uLpBqiS-CRg8IZQgiL6JhSVyeLUbafQ6ZUTew8ObuQrQZ6HDXEt984rmbTPLqbaJQsHyj1WaFmsFED2QRDigsu8PM8xxUpBGnUNgvG8lZl4ZMA6fm9zhftX_xgxasv6dW-azc5hQIEbliDEmL-dnJ3cM2h9UZKuMGI2u94Ij9ZtlQTCR-g54ejlE_hjsPaN9JZ1-Zn_ywDEoEQGv3uZw-kmDXt7ZOThMyfDp1-iSXyMh2KMxlcYYYxzDtlMeojWKlloKoI72NN6G-0yb106oIZjqU0zmIDDV3kbxkTMAKVQHTO4OwjQOqJA-_ww8=\" rel=\"nofollow\" target=\"_blank\">X<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=j7VInnrkem5RFipngbAJtGMB12dxZZ-mP0FAVDjV805U6AAqwLZ-136USQg7fcrDqG0RvsXIBycZ6b4oFnxT_2yTalMtk64PZmYzB9bdxACk3HQZRaREvk5IL04kegs-Ct6DP2z2Flv_pyr6M5xmSOrpTjbw_jbYVu_pyUvWropX53fIJQ0u2OwKxLfhuxPj9FYRtwEa2uezVhFYATOMLbSIS7sJcXUUCAQgc2k0iOTWkU3xLbkfY6YQzRvE3RghNbpT52NxnxbgKvBrVJwS6rbaPVsJefo7GDZUuDhYjLKODuqXln_nLS2e4a5Evxkr\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Relations<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Gilmartin Group<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>David Deuchler, CFA<br \/>+1 415-937-5400<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ZKGpJwbhYpor_hFQCUXum472u1VmXNJxu0t2KYCZVVYWNkBsHliHLX8HMsaIqK3fTb2vzDOY3XR9AJHMp8WBUA==\" rel=\"nofollow\" target=\"_blank\">ir@maxcyte.com<\/a><\/p>\n<p>\n        <strong>Media Relations<\/strong><br \/>\n        <br \/>\n        <strong><br \/>\n          <em>Oak Street Communications<\/em><br \/>\n        <\/strong><br \/>\n        <br \/>Kristen White<br \/>+1 415-608-6060<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=BMeeaWwkspRoP6fwEr_AZ7Cya0qj_zzCRC-uBr98gWliD_fc_Kpnsr94jt2AoT5npMY7hNj3R_wiJgMLK7rD4iYiuFafAoBCwExaM4rO01491GeTouambNt-w1n823k7ErKnNjM1o2XRG3IJ5r0-NA==\" rel=\"nofollow\" target=\"_blank\">kristen@oakstreetcommunications.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjNjYTRjZTAtMjAzYS00NDEwLWE5NDYtZmJkNWFhZDg0MTJiLTEyMTY3MzEtMjAyNS0wNy0wOS1lbg==\/tiny\/MaxCyte-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ROCKVILLE, Md., July 09, 2025 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2025 after the U.S. market close on Wednesday, August 6th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at https:\/\/investors.maxcyte.com\/. &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-867855","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ROCKVILLE, Md., July 09, 2025 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2025 after the U.S. market close on Wednesday, August 6th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at https:\/\/investors.maxcyte.com\/. &hellip; Continue reading &quot;MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-09T12:34:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025\",\"datePublished\":\"2025-07-09T12:34:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/\"},\"wordCount\":262,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/\",\"name\":\"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=\",\"datePublished\":\"2025-07-09T12:34:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/","og_locale":"en_US","og_type":"article","og_title":"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - Market Newsdesk","og_description":"ROCKVILLE, Md., July 09, 2025 (GLOBE NEWSWIRE) &#8212; MaxCyte, Inc., (NASDAQ: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced that it will release financial results for the second quarter 2025 after the U.S. market close on Wednesday, August 6th, 2025. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. Earnings Conference Call Details Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the \u201cEvents\u201d section of the MaxCyte website at https:\/\/investors.maxcyte.com\/. &hellip; Continue reading \"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/","og_site_name":"Market Newsdesk","article_published_time":"2025-07-09T12:34:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025","datePublished":"2025-07-09T12:34:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/"},"wordCount":262,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/","name":"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=","datePublished":"2025-07-09T12:34:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTQ5MTIxMiM3MDM4MjExIzIyMDUxNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maxcyte-to-report-second-quarter-2025-financial-results-on-august-6-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MaxCyte to Report Second Quarter 2025 Financial Results on August 6, 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867855","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=867855"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/867855\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=867855"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=867855"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=867855"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}